पृष्ठभूमि

Aboriginal and Torres Strait Islander peoples, or First Nations Australians, have higher rates of some vaccine-preventable diseases (VPD) than non-Indigenous Australians. This is due to a variety of factors, including access barriers to health care and preventative care, higher burden of chronic medical conditions and social determinants such as overcrowding and socioeconomic factors. For this reason, Aboriginal and Torres Strait Islander peoples are prioritised for additional protection through the funding of further vaccines on the National Immunisation Program (NIP). 

Variations to recommendations for additional vaccines vary from state to state, based on local disease burden. In addition to this, individual immunisation providers (e.g. hospital immunisation services) may have varying approaches to additional vaccines; this should be clarified with the local health service.

Recommendations

All First Nations Australians are recommended to receive the same vaccines given to non-Indigenous Australians. Additional vaccines prioritised के लिए First Nations Australiansre summarised in the table below. 

Table 1: NIP-funded vaccine priorities for Aboriginal and Torres Strait Islander peoples 

WordPress Tables Plugin

^ Refer to एमवीईसी: मेनिंगोकोकल for specific medical conditions and vaccination guidance.
# If Pneumovax 23 is inadvertently given before Prevenar 13 dose, wait 12 months before administering Prevenar 13.
* Shingrix vaccination is funded from 18 years of age for those with a history of haematopoietic stem cell transplant, solid organ transplant, blood cancer and advanced/untreated HIV).
¥ If 6-month dose is not given, refer to ऑस्ट्रेलियाई टीकाकरण पुस्तिका for catch up advice.
shaded boxes indicate live attenuated vaccines

Vaccine-preventable diseases (VPD) targeted through funding

  • हेपेटाइटिस ए

    Factors associated with hepatitis A transmission include (but are not limited to) overcrowding and poor sanitation conditions. Before the introduction of the NIP-funded Hepatitis A vaccination program, Hepatitis A was particularly prevalent in Aboriginal and Torres Strait Islander communities. Rates in First Nations children aged under 5 years were over 20 times higher than those in non-Indigenous children in the same age group. This disease burden was most prominent in more remote areas, particularly in northern Australia.  

    For more information, refer to Australian Immunisation Handbook: Hepatitis A

  • Herpes zoster (shingles)

    Herpes zoster (shingles) is caused by a reactivation of the varicella zoster virus, the same virus that causes छोटी चेचक (chickenpox) disease. Zoster episodes requiring primary care presentation and/or hospitalisation impact Aboriginal and Torres Strait Islander people at an earlier age than non-Indigenous Australians. In addition, the increased burden of chronic and complex diseases means that First Nations Australians are more likely to develop herpes zoster and its associated complications compared with other Australians.  

    For more information, refer to एमवीईसी: ज़ोस्टर

  • इन्फ्लूएंजा

    First Nations Australians are three times more likely than non-Indigenous people to be admitted to hospital for influenza and pneumonia. Vaccination can offer protection against disease and its complications. 

    For more information, refer to MVEC: Influenza page

  • मेनिंगोकोक्सल

    First Nations Australians have a 10-fold increased incidence of invasive meningococcal disease compared to non-Indigenous people across some age groups. Certain medical conditions further increase the likelihood of experiencing disease (e.g. immunosuppression, asplenia). Protection is offered through vaccination at the ages where disease affects individuals at the highest rates. 

    For more information, refer to एमवीईसी: मेनिंगोकोकल

  • न्यूमोकोकल

    Rates of invasive pneumococcal disease (IPD) are 6 to 7 times higher for Aboriginal and Torres Strait Islander peoples compared with non-Indigenous Australians. The risk of invasive pneumococcal disease  (IPD) is greatest in young children under 5 and adults over 50 years. Protection is offered through vaccination at the ages where disease affects individuals at the highest rates. 

    For more information, refer to एमवीईसी: न्यूमोकोकल

  • क्षय रोग

    In most areas of Australia, rates of tuberculosis are similar for First Nations Australians and non-Indigenous Australians. However, there are some specific regions where the burden of disease is higher amongst First Nations people. The reasons for this increased burden are varied; it may be associated with high density living conditions (contributing to ease of transmission) and being in close proximity to other countries with high rates of disease (contributing to imported cases by travellers).  

    For more information about tuberculosis vaccination (with advice specific to Victoria), refer to MVEC: Tuberculosis

Access

Easyccess को vaccines है important. High vaccine coverage and being vaccinated on time are key को reducing the burden of many VPDs among Aboriginal and Torres Strait Islander peopleएस.

All routine and additional immunisations can be administered via GP services, परिषदों, hospital immunisation services, some pharmacies and local Aboriginal Health Services.

Other considerations

Individuals may also benefit from other vaccines not previously mentioned on this page, depending on other factors, such as: 

  • vaccination history 
  • medical conditions
  • sexual orientation
  • proximity to local outbreaks
  • travel plans
  • occupational risk.

लेखक: राचेल मैकगायर (एमवीईसी शिक्षा नर्स समन्वयक), निगेल क्रॉफर्ड (निदेशक एसएईएफवीआईसी, मर्डोक चिल्ड्रेन रिसर्च इंस्टीट्यूट) और रेबेका फ़ोर (टीकाकरण नर्स, द रॉयल चिल्ड्रेन हॉस्पिटल)

द्वारा समीक्षित: Rachael McGuire (MVEC Education Nurse Coordinator) and Katie Butler (MVEC Education Nurse Coordinator)

तारीख: December 2023

नई जानकारी और टीके उपलब्ध होते ही इस अनुभाग की सामग्रियों को अद्यतन किया जाता है। मेलबर्न वैक्सीन एजुकेशन सेंटर (MVEC) कर्मचारी सटीकता के लिए नियमित रूप से सामग्रियों की समीक्षा करते हैं।

You should not consider the information on this site to be specific, professional medical advice for your personal health or for your family’s personal health. For medical concerns, including decisions about vaccinations, medications and other treatments, you should always consult a healthcare professional.